The Peterson Group to Join Medicrime Convention

Counterfeiting has been a long-time issue among health advocates. It has brought frustrations and arguments on top of complaints on the seemingly unsolvable problem. Dozens of seminars and raids have already been conducted to abolish counterfeiting but the business just seems to get bigger. It is already being considered in many reviews as one of the most lucrative criminal business around the world.

With the world in danger of falling victim to counterfeit medicines, a lot of NGOs, government agencies and international organizations are summing up ideas on the best approach to defeat fraudulent practice on drug production, exportation, importation and distribution. European nations have been leading the campaign against counterfeiting even with lower counterfeiting cases than the United States. Asia, with its diversified cultures, variety of languages, and numerous traditions falls behind the battle considering it is also a home to the most number of counterfeit drugs and the largest producer of illegal medicines.

Tired of all the intrigues on the inadequacy of the authorities to take down the groups behind these scams, the Medicrime Convention of the Council of Europe sets the first international standard for criminalizing the manufacture and distribution of counterfeit medicines. The Peterson Group, with foundations in Jakarta, Indonesia and Kuala Lumpur, Malaysia, has readily signed up as one of the active members among dozens of non-profit organizations who also participated in the cause. 24 other countries also signed the agreement which is to be ratified on January 1, 2016.

Headed by the Council of Europe with 60 years of experience in promoting healthy and quality medicines, this innovative treaty is adopted in 2010 by Medicrime Convention is designed as the first international medical treaty with the main goal to protect the quality of medicines being distributed across countries.

Global pharmaceutical companies welcomed the entry of force by Medicrime convention.

According to an interview with Eduardo Pisani, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), strong legislative framework is needed to combat the rampant issue and Europe has the sense to lead international parties in strengthening the policies which has lacked stern implementation in the last few years.

The criminals who deliberately endanger the health and lives of the patient and the overall public have been undermining the confidence in public health system and should therefore be considered as a matter of urgency.

Advertisement

Share This Story